These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7580969)

  • 1. [The possible role of dopamine beta-monooxygenase in the pathogenesis of schizophrenia].
    Mailian KR; Boiadzhian AS; Melik-Pashaian MA; Aĭvazian VA; Karagezian KG
    Dokl Akad Nauk; 1995 Jun; 342(6):833-4. PubMed ID: 7580969
    [No Abstract]   [Full Text] [Related]  

  • 2. [The dopamine theory of schizophrenia: reduced serum dopamine beta hydroxylase activity in paranoid schizophrenia].
    Lipcsey A
    Orv Hetil; 1981 Feb; 122(8):483. PubMed ID: 7290692
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma copper and dopamine-beta-hydroxylase in schizophrenia.
    Baron M; Perlman R; Levitt M; Meltzer H; Gruen R; Asnis L
    Biol Psychiatry; 1982 Jan; 17(1):115-20. PubMed ID: 7059633
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduced serum dopamine-beta-hydroxylase activity in paranoid schizophrenia.
    Arató M; Bagdy G; Perényi A
    Biol Psychiatry; 1982 Jul; 17(7):853-4. PubMed ID: 6126229
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma dopamine-beta-hydroxylase in familial and sporadic paranoid schizophrenia.
    Markianos M; Rinieris P; Hatzimanolis J; Stefanis C
    Biol Psychiatry; 1990 May; 27(10):1176-8. PubMed ID: 2340326
    [No Abstract]   [Full Text] [Related]  

  • 6. [A study of plasma dopamine-beta-hydroxylase activity in patients with schizophrenia].
    Kuang PG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Nov; 15(4):193-7. PubMed ID: 7183426
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum dopamine-beta-hydroxylase activity in schizophrenia.
    Meltzer HY; Nasr SJ; Tong C
    Biol Psychiatry; 1980 Oct; 15(5):781-8. PubMed ID: 6106516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced serum dopamine-beta-hydroxylase activity in paranoid schizophrenics.
    Arató M; Bagdy G; Blümel F; Perényi A; Rihmer Z
    Pharmacopsychiatria; 1983 Jan; 16(1):19-22. PubMed ID: 6828551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative studies of various clinical and psychopharmacological parameters of schizoaffective psychosis and paranoid schizophrenia].
    Masiak M; Perzyński J; Nagay J; Marmurowska-Michałowska H; Olajossy M; Wysocka A
    Psychiatr Pol; 1990; 24(5):1-9. PubMed ID: 2131470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative research on some clinical and psychopharmacological parameters of reactive paranoid psychoses].
    Masiak M; Marmurowska-Michałowska H; Nagay J; Olajossy M; Perzyński J; Wysocka A
    Psychiatr Pol; 1993; 27(1):63-74. PubMed ID: 8098150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet monoamineoxidase activity in chronic schizophrenics.
    Gerbaldo H; Rozados RV; Filinger EJ
    Medicina (B Aires); 1985; 45(1):22-4. PubMed ID: 3880103
    [No Abstract]   [Full Text] [Related]  

  • 13. An effect of neuroleptic medication on plasma dopamine-beta-hydroxylase activity.
    DeLisi LE; Phelps BH; Wise CD; Apostoles PS; Bigelow L; Wyatt RJ
    Biol Psychiatry; 1981 Sep; 16(9):873-8. PubMed ID: 6117334
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma dopamine beta hydroxylase activity in chronic schizophrenic patients tested with single dose of 2-bromo-alpha ergocriptine (Parlodel).
    Vardi J; Flechter S; Oberman Z; Segal R; Shogan G; Haker O
    Encephale; 1981; 7(1):95-103. PubMed ID: 7227288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low plasma dopamine-beta-hydroxylase in demented schizophrenics.
    Markianos M; Tripodianakis J
    Biol Psychiatry; 1985 Jan; 20(1):98-101. PubMed ID: 3965042
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet gamma-aminobutyrate-alpha-ketoglutarate transaminase (GABA-T) in schizophrenia.
    White HL; Davidson JR; Miller RD; Faison LD
    Am J Psychiatry; 1980 Jun; 137(6):733-4. PubMed ID: 7377399
    [No Abstract]   [Full Text] [Related]  

  • 17. Secretion pattern of endogenous opioids in chronic schizophrenia.
    Brambilla F; Facchinetti F; Petraglia F; Vanzulli L; Genazzani AR
    Am J Psychiatry; 1984 Oct; 141(10):1183-9. PubMed ID: 6091463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low levels of dopamine beta-hydroxylase and psychosis.
    Ewing JA; Mueller RA; Rouse BA; Silver D
    Am J Psychiatry; 1977 Aug; 134(8):927-8. PubMed ID: 879361
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity.
    Baron M; Levitt M; Asnis L; Fein M
    Biol Psychiatry; 1983 May; 18(5):579-82. PubMed ID: 6860731
    [No Abstract]   [Full Text] [Related]  

  • 20. Paranoid schizophrenia and platelet MAO activity.
    Baron M; Perlman R; Levitt M
    Am J Psychiatry; 1980 Nov; 137(11):1465-6. PubMed ID: 7435694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.